![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://ars.els-cdn.com/content/image/1-s2.0-S0006295218300297-fx1.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://images.novusbio.com/images/nbp1-97308_rabbit-polyclonal-glp-1r-antibody-310202415175291.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://media.biocompare.com/m/37/images/ihc-immunohistchemistry-20381641-400x300.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://static.wixstatic.com/media/1f382d_7e3cdf67a9c842d3b969a032e76991ff~mv2.jpg/v1/fill/w_568,h_192,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/1f382d_7e3cdf67a9c842d3b969a032e76991ff~mv2.jpg)
glp-1 antibody
Shipping Estimate
glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |
USD26.77
USD76.77
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-epr4042-407-ab111125--multiplex-immunohistochemistry-img460297.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://7tmantibodies.com/media/image/0e/a7/16/GLP1-IHC-F1.png)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-24h1l3-ab200474--western-blot-img44844.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication. Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep26236/MediaObjects/41598_2016_Article_BFsrep26236_Fig3_HTML.jpg)
![semaglutide gastroparesis law firm in west virginia glp-1 gastroparesis attorney in west virginia Victoza Lawsuit [2026 Update]](https://www.torhoermanlaw.com/wp-content/uploads/2021/07/Victoza-Lawsuit-Gastroparesis-Stomach-Paralysis-and-Other-Gastrointestinal-Injuries-Torhoerman-Law.jpg)
